La ruleta en línea es un juego muy aclamado por la mayoría de los jugadores de los casinos con dinero real en España, ya que el sistema es muy sencillo, pues consiste en apostar y predecir en qué casilla caerá la bola. Uno de los aspectos más sobres …
El origen de la ruleta: los tipos y las reglas de juego Read More »
OncoVent Co., Ltd., a majority-controlled subsidiary of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., yesterday entered into a license agreement with Orient EuroPharma Co., Ltd..
Evotec SE reported preliminary financial results and corporate updates for the fiscal year ended 31 December 2022.
Biovica, active in cancer monitoring, announces that the company has signed a commercial partnership with the European distributor TOROMEDICAL group for the commercialization of the DiviTumTKa test for clinical routine use in the Netherlands and Poland.
Biovica signs DiviTum(R) TKa Commercial Partner Agreement for Dutch and Polish Markets Read More »
Captor Therapeutics S.A. discloses the identity of the drug targets as well as associated supporting data, and provides an update on the progress in the research and development of its pipeline lead programs CT-01, CT-02 and CT-05.
HaemaLogiX Ltd announced that its anti-KMA CAR-T cell preclinical development has been completed and is the subject of an abstract accepted for poster presentation at the 2023 Annual Meeting of the American Association for Cancer Research, held 14-19 April in Orange County.
HaemaLogiX to present final data from anti-KMA CAR-T preclinical studies at AACR Read More »
Vifor Fresenius Medical Care Renal Pharma is pleased to announce that Tavneos® has been included in the revised EULAR AAV management recommendations, as one of several important updates in the 2022 version.
Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAV Read More »
H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio announced the availability of the Lumipulse G NfL CSF and Lumipulse G NfL Blood assays for the fully automated random-access LUMIPULSE® G immunoassay systems.
Acepodia announced the upcoming poster presentation of new preclinical data for ACE2016, a gamma delta-2 T cell therapy designed to target EGFR expressing solid tumors.
InnoCare Pharma, a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced 2022 annual results as of 31 December 2022.
InnoCare Releases 2022 Annual Results and Business Highlights Read More »
